Comparative Functional Outcomes After Corneal Crosslinking Using Standard, Accelerated, and Accelerated With Higher Total Fluence Protocols.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 27 1 2019
medline: 2 5 2019
entrez: 26 1 2019
Statut: ppublish

Résumé

To compare the relative 12-month corneal crosslinking (CXL) functional outcomes using standard protocol and accelerated protocols in patients with progressive keratoconus. CXL was performed using 3 epithelium-off protocols: standard [3 mW/cm for 30 minutes, 5.4 J/cm (S3/30-CXL)], accelerated with equivalent total irradiance [9 mW/cm for 10 minutes, 5.4 J/cm (A9/10-CXL)], and accelerated with increased total irradiance [30 mW/cm for 4 minutes, 7.2 J/cm (A30/4-CXL)]. Efficacy measurements were evaluated 12 months after treatment with Scheimpflug imaging (Pentacam HR) and included change in maximum keratometry (K Max), corrected distance visual acuity (CDVA), other keratometric variables, pachymetry, keratoconus indices, astigmatism, asphericity, manifest refraction, and higher order aberrations. Ninety-three eyes (67 patients) were evaluated: 35 eyes (26 patients) with S3/30-CXL, 29 eyes (19 patients) with A9/10-CXL, and 29 eyes (22 patients) with A30/4-CXL. Mean [INCREMENT]K Max was -1.53 ± 2.1 diopter (D) for S3/30-CXL, -0.71 ± 1.3 D for A9/10-CXL, and -0.70 ± 2.3 D for A30/4-CXL (P = 0.37). Mean [INCREMENT]CDVA(logMAR) was -0.18 ± 0.2 for S3/30-CXL, -0.13 ± 0.2 for A9/10-CXL, and -0.18 ± 0.2 for A30/4-CXL (P = 0.79). [INCREMENT]K Mean (r = -0.29 to -0.46), anterior asphericity (r = -0.34 to -0.40), and central keratoconus index (r = -0.18 to -0.38) best correlated with [INCREMENT]CDVA. S3/30-CXL had greater changes in index of surface variance, index of vertical asymmetry, keratoconus index, and regularization index compared to A9/10-CXL and A30/4-CXL. There were no other differences between protocols. All 3 protocols showed improvements in K Max, CDVA, and other variables, with similar functional outcomes for each despite greater change in keratoconus indices after S3/30-CXL. Correlations between change in measured variables and CDVA were poor overall; however, K Mean, central keratoconus index, and anterior asphericity were better correlated with CDVA than K Max.

Identifiants

pubmed: 30681515
doi: 10.1097/ICO.0000000000001878
doi:

Substances chimiques

Cross-Linking Reagents 0
Photosensitizing Agents 0
Collagen 9007-34-5
Riboflavin TLM2976OFR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

433-441

Commentaires et corrections

Type : CommentIn

Auteurs

Paul Z Lang (PZ)

Keck School of Medicine of USC, Los Angeles, CA.

Nikki L Hafezi (NL)

ELZA Institute, Dietikon, Zurich, Switzerland.

Sumitra S Khandelwal (SS)

Baylor College of Medicine, Cullen Eye Institute, Houston, TX.

Emilio A Torres-Netto (EA)

ELZA Institute, Dietikon, Zurich, Switzerland.
Ocular Cell Biology Group, University of Zurich, Zurich, Switzerland.
Paulista School of Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil.

Farhad Hafezi (F)

Keck School of Medicine of USC, Los Angeles, CA.
ELZA Institute, Dietikon, Zurich, Switzerland.
Ocular Cell Biology Group, University of Zurich, Zurich, Switzerland.
University of Wenzhou, Wenzhou, China.
University of Southern California, Roski Eye Institute, Los Angeles, CA.

J Bradley Randleman (JB)

Keck School of Medicine of USC, Los Angeles, CA.
University of Southern California, Roski Eye Institute, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH